NCT03838185View on ClinicalTrials.gov

Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
Alzheimer's Disease
Interventions
DRUG

J147

Single oral dose of J147

DRUG

Placebo

Single oral dose of corn oil

Trial Locations (1)

66206

Vince & Associates Clinical Research, Inc., Overland Park

Sponsors
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Abrexa Pharmaceuticals, Inc.

INDUSTRY

NCT03838185 - Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 | Biotech Hunter | Biotech Hunter